Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07743476
Status
Recruiting
Apply to this trial

Conditions

  • Bone Marrow
  • Hematologic
  • Oncologic

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Data Collection — OTHER
    Clinical, imaging, laboratory, treatment, and outcome data will be collected from institutional records and research assessments, as applicable.

Study Details

An observational study of patients with hematologic, oncologic, and other relevant conditions undergoing bone marrow imaging, with longitudinal collection of imaging, treatment, and clinical outcome data to characterize bone marrow features and changes over time

Key Dates

First listed
Aug 4, 2026
Start date
Aug 31, 2026
Status verified
Sep 2026
Primary completion
Dec 31, 2036
Completion
Dec 31, 2038

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Bone marrow imaging characteristics. [ Time Frame: Through study completion; an average of 1 year. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UT MD Anderson Cancer CenterHoustonTexas77030
Omran Saifi, MD
[email protected]
832-829-0337
Omran Saifi, MD (SUB_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
UT MD Anderson Cancer Center· Houston, TX

Related Studies